Anthony H Nguyen

Array ( [id] => 1504115 [patent_doc_number] => 06465439 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Pharmaceutical compositions' [patent_app_type] => B1 [patent_app_number] => 09/254322 [patent_app_country] => US [patent_app_date] => 1999-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7193 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465439.pdf [firstpage_image] =>[orig_patent_app_number] => 09254322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209404 [patent_doc_number] => 06110462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Enzymatic DNA molecules that contain modified nucleotides' [patent_app_type] => 1 [patent_app_number] => 9/262142 [patent_app_country] => US [patent_app_date] => 1999-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 30795 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110462.pdf [firstpage_image] =>[orig_patent_app_number] => 262142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1473894 [patent_doc_number] => 06387617 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Catalytic nucleic acid and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/257503 [patent_app_country] => US [patent_app_date] => 1999-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 13954 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387617.pdf [firstpage_image] =>[orig_patent_app_number] => 09257503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1293110 [patent_doc_number] => 06622934 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Liquid spraying apparatus' [patent_app_type] => B1 [patent_app_number] => 09/255699 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10154 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/622/06622934.pdf [firstpage_image] =>[orig_patent_app_number] => 09255699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067872 [patent_doc_number] => 06008344 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Antisense modulation of phospholipase A2 group IV expression' [patent_app_type] => 1 [patent_app_number] => 9/255893 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26445 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008344.pdf [firstpage_image] =>[orig_patent_app_number] => 255893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4201135 [patent_doc_number] => 06013787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Antisense modulation of Smad4 expression' [patent_app_type] => 1 [patent_app_number] => 9/255888 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25715 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013787.pdf [firstpage_image] =>[orig_patent_app_number] => 255888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1473983 [patent_doc_number] => 06387643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity' [patent_app_type] => B1 [patent_app_number] => 09/252586 [patent_app_country] => US [patent_app_date] => 1999-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 16362 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387643.pdf [firstpage_image] =>[orig_patent_app_number] => 09252586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254574 [patent_doc_number] => 06207819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds' [patent_app_type] => 1 [patent_app_number] => 9/250075 [patent_app_country] => US [patent_app_date] => 1999-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12902 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 311 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207819.pdf [firstpage_image] =>[orig_patent_app_number] => 250075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411859 [patent_doc_number] => 06528517 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Synthesis of quinobenzoxazine analogues with topoisomerase II and quadruplex interactions for use as antineoplastic agents' [patent_app_type] => B1 [patent_app_number] => 09/245019 [patent_app_country] => US [patent_app_date] => 1999-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 31 [patent_no_of_words] => 22693 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528517.pdf [firstpage_image] =>[orig_patent_app_number] => 09245019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4123318 [patent_doc_number] => 06127124 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Fluorescence based nuclease assay' [patent_app_type] => 1 [patent_app_number] => 9/234237 [patent_app_country] => US [patent_app_date] => 1999-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10158 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127124.pdf [firstpage_image] =>[orig_patent_app_number] => 234237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190194 [patent_doc_number] => 06153599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Methoxyethoxy oligonucleotides for modulation of protein kinase C expression' [patent_app_type] => 1 [patent_app_number] => 9/117901 [patent_app_country] => US [patent_app_date] => 1999-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9091 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153599.pdf [firstpage_image] =>[orig_patent_app_number] => 117901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406941 [patent_doc_number] => 06309830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Human suppressor tRNA oligonucleotides and methods of use for same' [patent_app_type] => 1 [patent_app_number] => 9/229212 [patent_app_country] => US [patent_app_date] => 1999-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 13247 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309830.pdf [firstpage_image] =>[orig_patent_app_number] => 229212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915568 [patent_doc_number] => 06001992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Antisense modulation of novel anti-apoptotic bcl-2-related proteins' [patent_app_type] => 1 [patent_app_number] => 9/226568 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20558 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001992.pdf [firstpage_image] =>[orig_patent_app_number] => 226568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 553772 [patent_doc_number] => 07157098 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-02 [patent_title] => 'Gene therapy of tumors using non-viral delivery system' [patent_app_type] => utility [patent_app_number] => 09/225699 [patent_app_country] => US [patent_app_date] => 1999-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 6435 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157098.pdf [firstpage_image] =>[orig_patent_app_number] => 09225699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409692 [patent_doc_number] => 06300320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Modulation of c-jun using inhibitors of protein kinase C' [patent_app_type] => 1 [patent_app_number] => 9/225749 [patent_app_country] => US [patent_app_date] => 1999-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 19946 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300320.pdf [firstpage_image] =>[orig_patent_app_number] => 225749 [rel_patent_id] =>[rel_patent_doc_number] =>)